Zepp Health Past Earnings Performance
Past criteria checks 0/6
Zepp Health's earnings have been declining at an average annual rate of -66.2%, while the Electronic industry saw earnings growing at 13.7% annually. Revenues have been declining at an average rate of 20.7% per year.
Key information
-66.2%
Earnings growth rate
-66.4%
EPS growth rate
| Electronic Industry Growth | 15.3% |
| Revenue growth rate | -20.7% |
| Return on equity | -12.5% |
| Net Margin | -18.8% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Zepp Health Corporation (NYSE:ZEPP) Stock Catapults 26% Though Its Price And Business Still Lag The Industry
Aug 20
Calculating The Intrinsic Value Of Zepp Health Corporation (NYSE:ZEPP)
Aug 03Zepp Health Corporation (NYSE:ZEPP) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough
Apr 17Zepp Health Corporation's (NYSE:ZEPP) Price Is Right But Growth Is Lacking After Shares Rocket 30%
Dec 23Zepp Leaves Investors Guessing With Return To Profits, Tumbling Own-Brand Sales
Nov 24Can Zepp Health Find Its Way Back Up?
Jul 31Zepp Health Non-GAAP EPADS of -$0.23, revenue of $165.5M
Aug 25What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate?
Aug 12Zepp: Speculative, But With Potentially Great Rewards
Jun 08What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate?
Mar 16Is Zepp Health Corporation (NYSE:ZEPP) Worth US$3.8 Based On Its Intrinsic Value?
Feb 23Zepp Health Stuck In Rut As Global Chip Shortage, Covid Weigh
Jan 06When Should You Buy Zepp Health Corporation (NYSE:ZEPP)?
Dec 15Investors Will Want Zepp Health's (NYSE:ZEPP) Growth In ROCE To Persist
Oct 28Globally Minded Zepp Raises Eyebrows With New Ultra-Long Life Smartwatch
Oct 15Zepp: A Solid International Diversification Play
Oct 03Is It Too Late To Consider Buying Zepp Health Corporation (NYSE:ZEPP)?
Sep 13Zepp Health: Taking Over The Smart Health Wearables Market
Jul 14We Think Zepp Health (NYSE:ZEPP) Can Stay On Top Of Its Debt
Jul 07Revenue & Expenses Breakdown
How Zepp Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 209 | -39 | 69 | 46 |
| 30 Jun 24 | 237 | -25 | 64 | 44 |
| 31 Mar 24 | 296 | -25 | 68 | 47 |
| 31 Dec 23 | 352 | -30 | 71 | 51 |
| 30 Sep 23 | 417 | -40 | 79 | 56 |
| 30 Jun 23 | 492 | -41 | 85 | 62 |
| 31 Mar 23 | 587 | -49 | 98 | 71 |
| 31 Dec 22 | 601 | -42 | 101 | 75 |
| 30 Sep 22 | 665 | -25 | 103 | 70 |
| 30 Jun 22 | 766 | -16 | 106 | 71 |
| 31 Mar 22 | 924 | 14 | 111 | 80 |
| 31 Dec 21 | 983 | 22 | 110 | 81 |
| 30 Sep 21 | 1,017 | 34 | 103 | 85 |
| 30 Jun 21 | 1,114 | 38 | 111 | 95 |
| 31 Mar 21 | 991 | 26 | 102 | 87 |
| 31 Dec 20 | 986 | 35 | 95 | 82 |
| 30 Sep 20 | 968 | 47 | 86 | 81 |
| 30 Jun 20 | 877 | 63 | 71 | 71 |
| 31 Mar 20 | 861 | 73 | 66 | 67 |
| 31 Dec 19 | 835 | 82 | 62 | 62 |
| 30 Sep 19 | 689 | 67 | 53 | 53 |
| 30 Jun 19 | 603 | 57 | 51 | 45 |
| 31 Mar 19 | 575 | 58 | 47 | 39 |
| 31 Dec 18 | 530 | 16 | 45 | 38 |
| 30 Sep 18 | 462 | 4 | 39 | 33 |
| 30 Jun 18 | 389 | -10 | 30 | 30 |
| 31 Mar 18 | 367 | -22 | 29 | 30 |
| 31 Dec 17 | 315 | 7 | 24 | 24 |
| 30 Sep 17 | 287 | 8 | 24 | 21 |
| 31 Dec 16 | 224 | -2 | 19 | 19 |
| 31 Dec 15 | 138 | -9 | 14 | 9 |
Quality Earnings: ZEPP is currently unprofitable.
Growing Profit Margin: ZEPP is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ZEPP is unprofitable, and losses have increased over the past 5 years at a rate of 66.2% per year.
Accelerating Growth: Unable to compare ZEPP's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ZEPP is unprofitable, making it difficult to compare its past year earnings growth to the Electronic industry (-5%).
Return on Equity
High ROE: ZEPP has a negative Return on Equity (-12.48%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 11:40 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zepp Health Corporation is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jing Sun | China Renaissance Securities |
| Ang-Chi Lin | Citigroup Inc |
| null null | Credit Suisse |